Journal of Clinical Endocrinology & Metabolism, Vol 81, 192-198, Copyright © 1996 by Endocrine Society

ARTICLES

A novel point mutation in the translation initiation codon of the pre- pro-vasopressin-neurophysin II gene: cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus

J Rutishauser, M Boni-Schnetzler, J Boni, W Wichmann, T Huisman, MB Vallotton and ER Froesch
Department of Medicine, University Hospital, Zurich, Switzerland.

Autosomal dominant neurohypophyseal diabetes insipidus (ADNDI) is a rare variant of idiopathic central diabetes insipidus. Several different mutations in the human vasopressin-neurophysin II (AVP-NP II) gene have been described. We studied nine family members from three generations of an ADNDI pedigree at the clinical, morphological, and molecular levels. AVP concentrations were measured during diagnostic fluid restriction tests. Coronal and sagittal high resolution T1- weighted images of the pituitary were obtained from affected and healthy family members. PCR was used to amplify the AVP-NP II precursor gene, and PCR products were directly sequenced. Under maximal osmotic stimulation, AVP serum levels were close to or below the detection limit in affected individuals. Magnetic resonance imaging studies revealed the characteristic hyperintense ("bright spot") appearance of the posterior pituitary in two healthy family members. This signal was absent in all four ADNDI patients examined. The coding sequences of AVP and its carrier protein, neurophysin II, were normal in all family members examined. Affected individuals showed a novel single base deletion (G 227) in the translation initiation codon of the AVP-NP II signal peptide on one allele. The mutation in the AVP-NP II leader sequence appears to be responsible for the disease in this kindred, possibly by interfering with protein translocation. The absence of the hyperintense posterior pituitary signal in affected individuals could reflect deficient posterior pituitary function.

This article has been cited by other articles:

				Y.-W. Lee, K. W. Lee, J. W. Ryu, J. O. Mok, C.-S. Ki, H. K. Park, Y. J. Kim, S. J. Kim, D. W. Byun, K. I. Suh, et al. Mutation of Glu78 of the AVP-NPII Gene Impairs Neurophysin as a Carrier Protein for Arginine Vasopressin in a Family with Neurohypophyseal Diabetes Insipidus Ann. Clin. Lab. Sci., January 1, 2008; 38(1): 12 - 14. [Abstract] [Full Text] [PDF]

				M. A. Friberg, M. Spiess, and J. Rutishauser Degradation of Wild-type Vasopressin Precursor and Pathogenic Mutants by the Proteasome J. Biol. Chem., May 7, 2004; 279(19): 19441 - 19447. [Abstract] [Full Text] [PDF]

				J. T. Wahlstrom, M. J. Fowler, W. E. Nicholson, and W. J. Kovacs A Novel Mutation in the Preprovasopressin Gene Identified in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1963 - 1968. [Abstract] [Full Text] [PDF]

				C. P. Mahoney, E. Weinberger, C. Bryant, M. Ito, J. L. Jameson, and M. Ito Effects of Aging on Vasopressin Production in a Kindred with Autosomal Dominant Neurohypophyseal Diabetes Insipidus Due to the {Delta}E47 Neurophysin Mutation J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 870 - 876. [Abstract] [Full Text] [PDF]

				M. Nijenhuis, E. L. T. van den Akker, R. Zalm, A. A. M. Franken, A. P. Abbes, H. Engel, D. de Wied, and J. P. H. Burbach Familial Neurohypophysial Diabetes Insipidus in a Large Dutch Kindred: Effect of the Onset of Diabetes on Growth in Children and Cell Biological Defects of the Mutant Vasopressin Prohormone J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3410 - 3420. [Abstract] [Full Text] [PDF]

				A. P. Abbes, B. Bruggeman, E. L.T. van den Akker, M. R. de Groot, A. A.M. Franken, V. R. Drexhage, and H. Engel Identification of Two Distinct Mutations at the Same Nucleotide Position, Concomitantly with a Novel Polymorphism in the Vasopressin-Neurophysin II Gene (AVP-NP II) in Two Dutch Families with Familial Neurohypophyseal Diabetes Insipidus Clin. Chem., October 1, 2000; 46(10): 1699 - 1702. [Full Text] [PDF]

				B. Calvo, J. R. Bilbao, A. Rodríguez, M. D. Rodríguez-Arnao, and L. Castaño Molecular Analysis in Familial Neurohypophyseal Diabetes Insipidus: Early Diagnosis of an Asymptomatic Carrier J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3351 - 3354. [Abstract] [Full Text]

				C. Siggaard, S. Rittig, T. J. Corydon, P. H. Andreasen, T. G. Jensen, B. S. Andresen, G. L. Robertson, N. Gregersen, L. Bolund, and E. B. Pedersen Clinical and Molecular Evidence of Abnormal Processing and Trafficking of the Vasopressin Preprohormone in a Large Kindred with Familial Neurohypophyseal Diabetes Insipidus due to A Signal Peptide Mutation J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2933 - 2941. [Abstract] [Full Text]

				N. Beuret, J. Rutishauser, M. D. Bider, and M. Spiess Mechanism of Endoplasmic Reticulum Retention of Mutant Vasopressin Precursor Caused by a Signal Peptide Truncation Associated with Diabetes Insipidus J. Biol. Chem., July 2, 1999; 274(27): 18965 - 18972. [Abstract] [Full Text] [PDF]

				M. Ito, R. N. Yu, J. L. Jameson, and M. Ito Mutant Vasopressin Precursors That Cause Autosomal Dominant Neurohypophyseal Diabetes Insipidus Retain Dimerization and Impair the Secretion of Wild-type Proteins J. Biol. Chem., March 26, 1999; 274(13): 9029 - 9037. [Abstract] [Full Text] [PDF]

				F. D. Grant, A. Ahmadi, C. M. Hosley, and J. A. Majzoub Two Novel Mutations of the Vasopressin Gene Associated with Familial Diabetes Insipidus and Identification of an Asymptomatic Carrier Infant J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3958 - 3964. [Abstract] [Full Text]

				P. S. Kim and P. Arvan Endocrinopathies in the Family of Endoplasmic Reticulum (ER) Storage Diseases: Disorders of Protein Trafficking and the Role of ER Molecular Chaperones Endocr. Rev., April 1, 1998; 19(2): 173 - 202. [Abstract] [Full Text]

				B. Calvo, J. R. Bilbao, I. Urrutia, J. Eizaguirre, S. Gaztambide, and L. Castaño Identification of a Novel Nonsense Mutation and a Missense Substitution in the Vasopressin-Neurophysin II Gene in Two Spanish Kindreds with Familial Neurohypophyseal Diabetes Insipidus J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 995 - 997. [Abstract] [Full Text]

				C. Heppner, J. Kotzka, C. Bullmann, W. Krone, and D. Müller-Wieland Identification of Mutations of the Arginine Vasopressin-Neurophysin II Gene in Two Kindreds with Familial Central Diabetes Insipidus J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 693 - 696. [Abstract] [Full Text]

				P. C. Gagliardi, S. Bernasconi, and D. R. Repaske Autosomal Dominant Neurohypophyseal Diabetes Insipidus Associated with a Missense Mutation Encoding Gly23->Val in Neurophysin II J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3643 - 3646. [Abstract] [Full Text] [PDF]

				D. R. Repaske, R. Medlej, E. K. Gultekin, M. R. S. Krishnamani, G. Halaby, J. W. Findling, and J. A. Phillips III Heterogeneity in Clinical Manifestation of Autosomal Dominant Neurohypophyseal Diabetes Insipidus Caused by a Mutation Encoding Ala-1->Val in the Signal Peptide of the Arginine Vasopressin/Neurophysin II/Copeptin Precursor J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 51 - 56. [Abstract] [Full Text] [PDF]